Loading...
B cell targeted therapies in autoimmune disease
PURPOSE OF REVIEW: FDA approved B cell targeted therapy has expanded to a multitude of autoimmune diseases ranging from organ specific diseases, like pemphigus and multiple sclerosis, to systemic diseases such as ANCA associated vasculitis, rheumatoid arthritis (RA) and systemic lupus erythematosus...
Na minha lista:
| Udgivet i: | Curr Opin Immunol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6982404/ https://ncbi.nlm.nih.gov/pubmed/31733607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2019.09.004 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|